TRISODIUM 4-(4-(2-(5-((4-((2-CARBOXY-4-SULFONATOPHENYL)AMINO)-6-CHLORO-1,3,5-TRIAZIN-2-YL)AMINO)-2-SULFONATOPHENYL)DIAZEN-1-YL)-3-METHYL-5-OXO-4H-PYRAZOL-1-YL)-2,5-DICHLOROBENZENESULFONATE
UNII G885USP69R
Substance Identification & Data
This profile provides standardized clinical and technical data for Trisodium 4-(4-(2-(5-((4-((2-carboxy-4-sulfonatophenyl)amino)-6-chloro-1,3,5-triazin-2-yl)amino)-2-sulfonatophenyl)diazen-1-yl)-3-methyl-5-oxo-4h-pyrazol-1-yl)-2,5-dichlorobenzenesulfonate, uniquely identified by the FDA Unique Ingredient Identifier (UNII) G885USP69R.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 93778-50-8 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C26H15Cl3N9O12S3.3Na JRIBXPOBBZBHLH-ZRCOUJIOSA-K Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for Trisodium 4-(4-(2-(5-((4-((2-carboxy-4-sulfonatophenyl)amino)-6-chloro-1,3,5-triazin-2-yl)amino)-2-sulfonatophenyl)diazen-1-yl)-3-methyl-5-oxo-4h-pyrazol-1-yl)-2,5-dichlorobenzenesulfonate. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.